A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.


Updates from The Motley Fool

Latest updates on PDL BioPharma from Fool.com.


Stock Performance

PDLI vs. S&P 500 | 2 Year Performance
View Interactive PDLI Charts
Sponsored by

Key Data Points

Primary metrics and data points about PDL BioPharma.
Current Price: $3.35
Prev Close: $3.23
Open: $3.23
Bid: $3.22
Ask: $3.35
Day's Range: $3.21 - $3.37
52wk Range: $2.58 - $5.35
Volume: 1,708,492
Avg Vol 1,518,577
Market Cap: $548M
P/E (ttm): 2.26
EPS (ttm): $1.43
Div & Yield: $0.60 (6.2%)

Company Rating

What our community thinks about PDL BioPharma.
CAPS Rating 3 out of 5
 
840 Outperform
48 Underperform
CAPS All Stars
 
173 Outperform
11 Underperform

How do you think PDL BioPharma will perform against the market?



You pick for PDL BioPharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John P. McLaughlin, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for PDL BioPharma.

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers